Insulin Monopoly

This article explores the following key points:

  • Price-fixing by 3 companies.
  • Lobbying for life-saving meds.
  • Alternatives suppressed.
  • Global pricing disparities.
  • Fiat welfare to pharma corps.

Comments

Leave a Reply

Your email address will not be published. Required fields are marked *